Insider Transactions in Q1 2021 at Five Prime Therapeutics, Inc. (FPRX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Mar 31 2021	Helen Louise Collins EVP and Chief Medical Officer	SELL Bona fide gift	Direct	8,085 -10.41%	-
Feb 28 2021	David White Officer	SELL Payment of exercise price or tax liability	Direct	1,461 -4.19%	$32,142 $22.23 P/Share
Feb 26 2021	Helen Louise Collins EVP and Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	1,158 -1.47%	$25,476 $22.23 P/Share
Feb 26 2021	Francis Willard Sarena Chief Strategy Officer	SELL Payment of exercise price or tax liability	Direct	1,158 -0.93%	$25,476 $22.23 P/Share
Feb 25 2021	Helen Louise Collins EVP and Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	1,653 -2.05%	$38,019 $23.08 P/Share
Feb 25 2021	Francis Willard Sarena Chief Strategy Officer	SELL Payment of exercise price or tax liability	Direct	1,653 -1.31%	$38,019 $23.08 P/Share
Feb 24 2021	David White Officer	SELL Payment of exercise price or tax liability	Direct	1,155 -3.2%	$28,875 $25.71 P/Share
Feb 24 2021	David V Smith Executive Vice President & CFO	SELL Payment of exercise price or tax liability	Direct	5,110 -6.55%	$127,750 $25.71 P/Share
Feb 24 2021	Helen Louise Collins EVP and Chief Medical Officer	SELL Payment of exercise price or tax liability	Direct	5,091 -5.95%	$127,275 $25.71 P/Share
Feb 24 2021	Francis Willard Sarena Chief Strategy Officer	SELL Payment of exercise price or tax liability	Direct	5,100 -3.88%	$127,500 $25.71 P/Share

Receive a notification when an Institution or Guru buys or sells FPRX shares.

Notify only if

Value

Get notified when an Five Prime Therapeutics, Inc. insider buys or sells FPRX shares.

Notify only if

Operation

Value

Type

Receive news related to FIVE PRIME THERAPEUTICS, INC.